CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L106

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
62,912,321
Share change
+18,290,365
Total reported value
$148,335,421
Put/Call ratio
28%
Price per share
$2.36
Number of holders
84
Value change
+$43,142,377
Number of buys
46
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q4 2014

As of 31 Dec 2014, CTI BIOPHARMA CORP - COM (CTIC) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 62,912,321 shares. The largest 10 holders included EAGLE ASSET MANAGEMENT INC, State Street Corp, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, RA CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and DAFNA Capital Management LLC. This page lists 84 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.